FDA’s Final Guidance Pushes Companies to be Recall Ready
In an effort to help companies be more recall ready, the FDA has finalized a guidance document that reviews how companies should have proper product coding and keep distribution records to facilitate faster and more accurate recall actions. The guidance, Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C, describes the steps that companies should take before a recall is necessary; and training, planning and record-keeping procedures that can limit public exposure to risk by reducing the amount of time a recalled product is on the market. The guidance applies to voluntary recalls of products under FDA’s jurisdiction.
The document provides guidance on the following:
- How a firm in a product distribution chain should prepare to facilitate timely initiation of a voluntary recall
- Recommended procedures for initiating a recall and performing actions related to initiating a recall
- What a firm should do if there is an indication of a problem with a distributed product
- How a firm should initiate a voluntary recall
- How FDA works with a recalling firm to initiate a voluntary recall in a timely manner
Related Articles
-
The center is proposing that Philips repair, replace or refund recalled devices manufactured after November 2015.
-
The new guidance is intended to establish confidence in automation used for production or quality assurance systems and describe various methods and testing activities that may be applied to establish computer software assurance and meet regulatory software validation requirements.
-
The updated guidance document clarifies what constitutes a statement of the basis for the deficiency and includes examples of well-constructed deficiencies and industry responses to facilitate a more efficient review process.
-
The revised cybersecurity draft publication is not intended to be a checklist for healthcare organizations to follow, but rather a guide to help them comply with the HIPAA Security Rule.
